IL104757A0 - Derivatives of saturated nitrogen heterocycles - Google Patents
Derivatives of saturated nitrogen heterocyclesInfo
- Publication number
- IL104757A0 IL104757A0 IL104757A IL10475793A IL104757A0 IL 104757 A0 IL104757 A0 IL 104757A0 IL 104757 A IL104757 A IL 104757A IL 10475793 A IL10475793 A IL 10475793A IL 104757 A0 IL104757 A0 IL 104757A0
- Authority
- IL
- Israel
- Prior art keywords
- derivatives
- saturated nitrogen
- nitrogen heterocycles
- heterocycles
- saturated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH46092 | 1992-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL104757A0 true IL104757A0 (en) | 1993-06-10 |
Family
ID=4187521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL104757A IL104757A0 (en) | 1992-02-17 | 1993-02-16 | Derivatives of saturated nitrogen heterocycles |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5322852A (no) |
| EP (1) | EP0558443A1 (no) |
| JP (1) | JPH069558A (no) |
| KR (1) | KR930017874A (no) |
| AU (1) | AU3298193A (no) |
| CA (1) | CA2089533A1 (no) |
| IL (1) | IL104757A0 (no) |
| TW (1) | TW214545B (no) |
| ZA (1) | ZA931064B (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3979664B2 (ja) * | 1995-03-15 | 2007-09-19 | ノバルティス・アクチエンゲゼルシャフト | プトレッシン、スペルミジンおよびスペルミンなどの細胞内の内因性ポリアミンレベルを低下させるピペリジニル−２−アルキル置換直鎖ポリアミン、およびその細胞増殖に対する影響 |
| TWI220143B (en) * | 1998-05-13 | 2004-08-11 | Solvay Pharm Gmbh | Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds and novel cyclic compounds, and intermediate products |
| CA2932121A1 (en) * | 2007-11-30 | 2009-06-11 | Newlink Genetics Corporation | Ido inhibitors |
| CA2743700C (en) * | 2008-12-15 | 2016-07-12 | Taigen Biotechnology Co., Ltd. | Stereoselective synthesis of piperidine derivatives |
| JP5505175B2 (ja) | 2009-07-31 | 2014-05-28 | Ｊｓｒ株式会社 | 感放射線性樹脂組成物およびそれに用いられる化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ219646A (en) * | 1986-03-27 | 1990-10-26 | Merck Sharp & Dohme | Oxadiazole derivatives of azacyclics for treating cns disorders |
| EP0369944A1 (de) * | 1988-11-18 | 1990-05-23 | Ciba-Geigy Ag | Substituierte Oxadiaminobutane |
| FR2644456B1 (fr) * | 1989-03-17 | 1991-07-05 | Rhone Poulenc Sante | Nouveaux derives du 1h, 3h-pyrrolo(1,2-c)thiazolecarboxamide-7, leur preparation et les compositions pharmaceutiques qui les contiennent |
| IL97759A0 (en) * | 1990-04-11 | 1992-06-21 | Ciba Geigy Ag | Hydroxylamine compounds |
| EP0495750A3 (en) * | 1991-01-14 | 1992-09-16 | Ciba-Geigy Ag | Heterocyclic hydroxylamine |
-
1993
- 1993-01-30 TW TW082100576A patent/TW214545B/zh active
- 1993-02-09 EP EP93810079A patent/EP0558443A1/de not_active Withdrawn
- 1993-02-10 AU AU32981/93A patent/AU3298193A/en not_active Abandoned
- 1993-02-11 US US08/016,407 patent/US5322852A/en not_active Expired - Lifetime
- 1993-02-15 CA CA002089533A patent/CA2089533A1/en not_active Abandoned
- 1993-02-16 ZA ZA931064A patent/ZA931064B/xx unknown
- 1993-02-16 IL IL104757A patent/IL104757A0/xx unknown
- 1993-02-16 JP JP5026685A patent/JPH069558A/ja active Pending
- 1993-02-17 KR KR1019930002171A patent/KR930017874A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU3298193A (en) | 1993-08-19 |
| TW214545B (no) | 1993-10-11 |
| JPH069558A (ja) | 1994-01-18 |
| ZA931064B (en) | 1993-08-17 |
| CA2089533A1 (en) | 1993-08-18 |
| US5322852A (en) | 1994-06-21 |
| EP0558443A1 (de) | 1993-09-01 |
| KR930017874A (ko) | 1993-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9302246D0 (en) | Substituted heterocyclic compounds containing nitrogen | |
| PL307812A1 (en) | Substituted thiazolydinone derivatives | |
| ZW1492A1 (en) | Nitrogen heterocycles | |
| ZA93324B (en) | Heterocyclic derivatives | |
| HU9500330D0 (en) | Amide derivatives | |
| IL104757A0 (en) | Derivatives of saturated nitrogen heterocycles | |
| CZ164595A3 (en) | Difluoropentapeptide derivatives of antiphlogistic agents | |
| GB2271564B (en) | Thioalkylthio carbacephalosporin derivatives | |
| GB2270913B (en) | Chlordifluoromethoxyphenyl derivatives | |
| HU9300556D0 (en) | Substituted phenyl-quinazoline derivatives | |
| EP0565961A3 (en) | Ethyl-triazolyl derivatives | |
| GB9202633D0 (en) | Heterocyclic derivatives | |
| GB9216783D0 (en) | Heterocyclic derivatives | |
| GB9204464D0 (en) | New heterocyclic derivatives | |
| GB9216772D0 (en) | Nitrogen derivatives | |
| GB9213474D0 (en) | Nitrogen derivatives | |
| GB9211290D0 (en) | Nitrogen derivatives | |
| GB9201429D0 (en) | Nitrogen derivatives | |
| GB2305171B (en) | Amide derivatives | |
| GB9218781D0 (en) | Heterocyclic derivatives | |
| GB9206421D0 (en) | Heterocyclic derivatives | |
| GB9200633D0 (en) | Heterocyclic derivatives | |
| GB9226574D0 (en) | Heterocyclic derivatives | |
| GB9208387D0 (en) | Heterocyclic derivatives | |
| GB9218335D0 (en) | Heterocyclic derivatives |